Human immunodeficiency virus (HIV) type 1 Vpr induces differential regulation of T cell costimulatory molecules: direct effect of Vpr on T cell activation and immune function
- PMID: 17023015
- DOI: 10.1016/j.virol.2006.08.030
Human immunodeficiency virus (HIV) type 1 Vpr induces differential regulation of T cell costimulatory molecules: direct effect of Vpr on T cell activation and immune function
Abstract
Human immunodeficiency virus type 1 (HIV-1) viral proteins disrupt the normal host cellular immune pathways thus exploiting the cellular machinery for replication, survival and to escape host immune attack. Here we evaluated the direct effects of HIV-1 Vpr-mediated immune modulation of infected T cells. Vpr specifically downregulated the expression of CD28 and increased the expression of CTLA-4, whereas no significant difference in the expression of CD25 and HLA-DR was observed. Interferon gamma (IFN-gamma) production in T cells was evaluated as a measure of the downstream effector functions. Results indicate that Vpr significantly inhibited IFN-gamma production and this may, in part, due to Vpr's ability to inhibit the nuclear translocation of NF-kappaB, and its transcriptional regulation. Together these results support that HIV-1 Vpr selectively dysregulates the immune functions at multiple levels and exerts its inhibitory effects in the presence of other viral proteins.
Similar articles
-
Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape.J Virol. 2005 Jul;79(13):7990-8003. doi: 10.1128/JVI.79.13.7990-8003.2005. J Virol. 2005. PMID: 15956545 Free PMC article.
-
HIV-1 Viral protein-r (Vpr) protects against lethal superantigen challenge while maintaining homeostatic T cell levels in vivo.Mol Ther. 2005 Nov;12(5):910-21. doi: 10.1016/j.ymthe.2005.05.009. Epub 2005 Jul 11. Mol Ther. 2005. PMID: 16006193
-
Inhibition of NF-κB activity by HIV-1 Vpr is dependent on Vpr binding protein.J Cell Physiol. 2013 Apr;228(4):781-90. doi: 10.1002/jcp.24226. J Cell Physiol. 2013. PMID: 23001849 Free PMC article.
-
Mechanism of HIV-1 viral protein R-induced apoptosis.Biochem Biophys Res Commun. 2003 May 9;304(3):583-92. doi: 10.1016/s0006-291x(03)00631-4. Biochem Biophys Res Commun. 2003. PMID: 12729593 Review.
-
HIV-1 Vpr and anti-inflammatory activity.DNA Cell Biol. 2004 Apr;23(4):239-47. doi: 10.1089/104454904773819824. DNA Cell Biol. 2004. PMID: 15142381 Review.
Cited by
-
HIV-1 infection of DC: evidence for the acquisition of virus particles from infected T cells by antigen uptake mechanism.PLoS One. 2009 Oct 15;4(10):e7470. doi: 10.1371/journal.pone.0007470. PLoS One. 2009. PMID: 19829715 Free PMC article.
-
Human immunodeficiency virus type 1 Vpr polymorphisms associated with progressor and nonprogressor individuals alter Vpr-associated functions.J Gen Virol. 2014 Mar;95(Pt 3):700-711. doi: 10.1099/vir.0.059576-0. Epub 2013 Dec 3. J Gen Virol. 2014. PMID: 24300552 Free PMC article.
-
T-Cell Signaling in HIV-1 Infection.Open Virol J. 2013 Jul 26;7:57-71. doi: 10.2174/1874357920130621001. eCollection 2013. Open Virol J. 2013. PMID: 23986795 Free PMC article.
-
Immunological dysfunction in HIV-1-infected individuals caused by impairment of adenosine deaminase-induced costimulation of T-cell activation.Immunology. 2009 Nov;128(3):393-404. doi: 10.1111/j.1365-2567.2009.03121.x. Immunology. 2009. PMID: 20067539 Free PMC article.
-
Infection with Vpr-positive human immunodeficiency virus type 1 impairs NK cell function indirectly through cytokine dysregulation of infected target cells.J Virol. 2008 Jul;82(14):7189-200. doi: 10.1128/JVI.01979-07. Epub 2008 Apr 16. J Virol. 2008. PMID: 18417583 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
